Main Management ETF Advisors, LLC Ascendis Pharma A/S Transaction History
Main Management ETF Advisors, LLC
- $2.21 Billion
- Q4 2024
A detailed history of Main Management ETF Advisors, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 5,696 shares of ASND stock, worth $863,114. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,696
Previous 6,208
8.25%
Holding current value
$863,114
Previous $927,000
15.43%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
60.2MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.53 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$838 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$773 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$674 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$664 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.46B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...